{"name":"Haihe Biopharma Co., Ltd.","slug":"haihe-biopharma-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"CYH33","genericName":"CYH33","slug":"cyh33","indication":"Other","status":"phase_2"},{"name":"Glumetinib","genericName":"Glumetinib","slug":"glumetinib","indication":"Other","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AL3810","genericName":"AL3810","slug":"al3810","indication":"Type 2 diabetes","status":"phase_2"}]}],"pipeline":[{"name":"AL3810","genericName":"AL3810","slug":"al3810","phase":"phase_2","mechanism":"AL3810 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"CYH33","genericName":"CYH33","slug":"cyh33","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Glumetinib","genericName":"Glumetinib","slug":"glumetinib","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE40Rl8wd1VFWGtXUlV3bXRzNmwzcllqc3V6MlVzODZOanNFV0xUU3pLS1ZmTUZNLTFjSldmWFRncjFCN1NlY01MemVjT3hCaU1KTDFFeWR3NXZzLVRYa0gwSGlRdGg3VmM?oc=5","date":"2025-11-27","type":"pipeline","source":"Failory","summary":"The Full List of 19 Pharmaceutical Unicorn Startups (2026) - Failory","headline":"The Full List of 19 Pharmaceutical Unicorn Startups (2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxNRjQ3VUh4R0ZtbmdYQmJiNDFOSm03MXFtYXl3dG9OWV9sdlNvRlEyWXBhUmxzN3VGWktRWktnQ05tUm1RSDNBSk1mZGgzTlJSMk1kMWxYelNXUE1VdDg2WGlieE8zYzE5Sl9KWHJXYlo5N2dtTUJaWDlrMkdOeFB3ckEzeEN5V2hZNlFvTktxMDNBamFjRFdKZWtramdlR0t0T2FCQmc2OGJiSGJhZGpDdlBkNUVFcWJ2eDV4WksyOGEtQVVSbm1HWEt5WXZ1V29YTDlQTjB4d3JaUnZMOEV3ajg0U1FKTGNHdVc2aFNHWldFYXF0NTlQeWlsajJqWHJPX3NOQU8zVUdEazRUaDFBdlRGLVdYclpZSGdldWY4aWR6dw?oc=5","date":"2025-11-06","type":"trial","source":"PR Newswire","summary":"Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight - PR Newswire","headline":"Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immuno","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOaG5oYmUxOXdlRFRRQXMydEc0emVSWXhMUV9CSmJmMUdMUkVKSElaZjlOQmRVeXBOU1lia3huTl90d2wtS2lVSVpYb0Z2eWdoSG5Mb2hDbURrOUFiTFRjMmlvNnFaSGFRazZOekVvb1c0ck5sMnJLYWZ4dHhaMFVVYW9qWU5HTGNZU194S0wtaw?oc=5","date":"2024-05-29","type":"pipeline","source":"drugdiscoverytrends.com","summary":"100 of the best-funded private healthcare and biotech companies - drugdiscoverytrends.com","headline":"100 of the best-funded private healthcare and biotech companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZGREVG9zTkJJZE5kT2h3WWtZbjlhd2xXdU80bnJ4S0NfWDlKWWNUdjdQTDJqSXVFc21hX3MtWU5VaGRlQXNmMVdFM3lQVWF6enlsOG5LamxJYmUtZWxPUGVqckpOVV8zV3NrbEFFMlhOUUNvZEhVVGFpRWFoaGpLaENTTEw1aXdzak9GY3pESHFnZE9CZHN3bXpZVkRaQmFqNWd5SllpSE9SQQ?oc=5","date":"2024-03-27","type":"pipeline","source":"BioSpace","summary":"Biopharmaceuticals Contract Manufacturing Market Size To Hit USD 31.92 Bn By 2032 - BioSpace","headline":"Biopharmaceuticals Contract Manufacturing Market Size To Hit USD 31.92 Bn By 2032","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxONHJsVHR6aGJNbzdkUmFaVEpBNDZFQmlVeElxMVk0QUNXY3RDNUtka2xvaE1JOFVXV0JuWU94YzBQNEJoam5YLWJlZlBKWVFaXzh5VlYzaWJEZWpBRWZ3c0pHQVU0eGFjcFRkeEgxZ1d6bHhRdGhJdUdIV3dvUF95ekl5ejVrNk9uVmlVMXlB?oc=5","date":"2024-03-21","type":"trial","source":"Yahoo Finance","summary":"PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ Companies Working in the Domain - Yahoo Finance","headline":"PI3K Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 75+ C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5kRTFuYjdhT0hlMFR3bHJGcFJ0S3d0ZDB1bzN2NDBFY0YwMWlfTk5IbHhRaVA2LTRkZFowcU03Z0NPY3ZDajVxU0NncU5IdzFONklXaURvT3B4M1F0d2hV?oc=5","date":"2024-02-20","type":"regulatory","source":"nature.com","summary":"Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA - nature.com","headline":"Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOMWllZ1NkXzg2ZEVid2d1eldyYWpHaTZvMXZ1WlFMYUFPTXhvQ0JnVTdXWF9Vb0ZxVjRfN3FsNWFqRC0wWmpIdVJyT1RIdFJzUUxOcDNPNDlKVzRiTzZaWjlUZTZIY1luTXV0Mk9oMnVwSUl3c0twQTk5V21sT2ZRNUVoNFU4WVdTZFI2MER2dGRaQXNoRUFta2lkWENMVFIwS0E?oc=5","date":"2024-02-16","type":"pipeline","source":"Rockefeller University Press","summary":"EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation - Rockefeller University Press","headline":"EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1oODQ5N1pIdTktYkdIZFpSb3lLQno3dEhjUkd2MWFsRnVwYzBGa183ZnFlWk9GSFJzY3FSWUxJTGx1dXlNZ0U3RVMxZHU2SGpKMFJSaUFxWHNTR0VTWUVncGFoam5LQkxEU19qYTVR?oc=5","date":"2023-06-16","type":"regulatory","source":"KED Global","summary":"Daehwa Pharm applies for approval of anti-dementia patch in China - KED Global","headline":"Daehwa Pharm applies for approval of anti-dementia patch in China","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQbF9QOGNPTWI2QlViY2gtbWcwLUR0NlNSTVBkTmRSLTJ0MTlPX2VJS0pmYVcwZ2s2T3I4eDFxVTVQMHQ5c0hITHhnZFVZdnA1eTBlWVNCb1ZVcEZvR24zSmlIWWg1ejZxcWhnYWVpNmpzakVfNGYxYXpLcmNxRGVoSE1TZw?oc=5","date":"2022-05-16","type":"trial","source":"Yahoo Finance","summary":"Extensive Stage Small Cell Lung Cancer Pipeline Review | Clinical Trial Analysis by DelveInsight - Yahoo Finance","headline":"Extensive Stage Small Cell Lung Cancer Pipeline Review | Clinical Trial Analysis by DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":2,"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}